ArticleFrontiers in immunology2022

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.

Guoming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.